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Identifying biological roles for mammalian glycans and the
pathways by which they are synthesized has been greatly facili-
tated by investigations of glycosylation mutants of cultured cell
lines and model organisms. Chinese hamster ovary (CHO) gly-
cosylationmutants isolated on the basis of their lectin resistance
have been particularly useful for glycosylation engineering of
recombinant glycoproteins. To further enhance the application
of these mutants, and to obtain insights into the effects of alter-
ing one specific glycosyltransferase or glycosylation activity on
the overall expression of cellular glycans, an analysis of the
N-glycans and major O-glycans of a panel of CHOmutants was
performed using glycomic analyses anchored bymatrix-assisted
laser desorption ionization-time of flight/time of flight mass
spectrometry. We report here the complement of the major
N-glycans and O-glycans present in nine distinct CHO glycosy-
lation mutants. Parent CHO cells grown in monolayer versus
suspension culture had similar profiles ofN- andO-GalNAc gly-
cans, although the profiles of glycosylation mutants Lec1, Lec2,
Lec3.2.8.1, Lec4, LEC10, LEC11, LEC12, Lec13, and LEC30were
consistent with available genetic and biochemical data. How-
ever, the complexity of the range of N-glycans observed was
unexpected. Several of the complexN-glycan profiles contained
structures ofm/z13,000 representing complexN-glycanswith
a total of 26 N-acetyllactosamine (Gal1–4GlcNAc)n units.
Importantly, the LEC11, LEC12, and LEC30 CHO mutants
exhibited unique complements of fucosylated complex N-gly-
cans terminating in Lewisx and sialyl-Lewisx determinants. This
analysis reveals the larger-than-expected complexity of N-gly-
cans in CHO cell mutants that may be used in a broad variety of
functional glycomics studies and for making recombinant
glycoproteins.
TheN- andO-glycans that decorate glycoproteins at the cell
surface servemany key biological functions, and thus it is essen-
tial to understand their structures and the factors that influence
their synthesis. Mutants of mammalian cells affected in glyco-
sylation pathways are a valuable resource for experiments
aimed at structure/function analysis of mammalian glycans. A
panel of glycosylation mutants that has been widely used for
such purposes is the Chinese hamster ovary (CHO)4 mutant
lines isolated following selection for various plant lectins (1, 2).
These CHO mutants have been previously characterized bio-
chemically and genetically, but their glycans have only been
partially characterized structurally. In this study, we present
glycomics profiles of the N-linked and O-GalNAc glycans of
nine of the commonly used CHO glycosylation mutants, pro-
viding an important base line for future applications using these
mutants in functional and biochemical studies and for glycosy-
lation engineering. For example, it is very important to know
the range ofN-glycans thatmay be generated in the presence of
GlcNAcT-III, the glycosyltransferase that in vitro adds the
bisecting GlcNAc only to simple biantennary N-glycans (3).
Similar considerations apply for CHO mutants expressing an
-1,3-fucosyltransferase that in vitro generates the Lewisx (Lex)
and/or sialyl-Lewisx (sLex) determinants on comparatively sim-
ple acceptors (4). In hypomorphic mutants or mutants that are
defective in the synthesis of a nucleotide sugar or the activity of
a nucleotide sugar transporter, it is important to know the
stringency of the phenotype and thus the extent of the block in
glycosylation.
The development of sensitive methods of mass spectroscopy
has allowed the glycan complement of tissues and cells to be
examined in detail (5). Interpretation of masses obtained from
MALDI-TOF/TOF spectra is assisted by knowledge of the gly-
cosylation pathways involved and, in this paper, appreciation of
the genetic and biochemical alterations expressed by a mutant
phenotype (1). Here we present the N-glycan and O-GalNAc
glycan glycomics profiles of CHO parent cells and of the glyco-
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sylation mutants Lec1, Lec2, Lec3.2.8.1, Lec4, LEC10, LEC11,
LEC12, Lec13, and LEC30. The Lec8 cell line, which carries an
inactive UDP-Gal transporter and is also in common use, was
previously characterized byMALDI-MS (6). Fig. 1 summarizes
the glycan structures predicted to be affected in each mutant,
with the sites of glycosylation defects shown in terms of the
sugar residue(s) added for gain-of-function mutants () or the
sugar residues not transferred in the case of loss-of-function
mutants (). Table 1 summarizes the known biochemical basis
of each glycosylation mutation.
EXPERIMENTAL PROCEDURES
CHO Cells and Culture Methods—The CHO cells compared
by glycomics profiling were parental CHO (Pro5) and glyco-
sylation mutants selected from Pro5 cells for survival to cyto-
toxic plant lectins (reviewed in Ref. 1). The Pro5 line lacks
transcripts of B4galt6 (7). The lectin-resistant clones used
were as follows: Lec1.3C, Lec2.6A, Lec3.2.8.1.3B, Lec4.7B,
LEC10.3C, LEC11.E7, LEC12.1B, Lec13.6A, and LEC30.H2. For
simplicity, each clone is referred to by their Lec name in the
text. CHO parent cells were grown in suspension or monolayer
in -minimal essential medium containing nucleotides and
ribonucleosides (Invitrogen) and containing 10% fetal bovine
serum (Gemini, West Sacramento, CA) at 37 °C in 5% CO2.
Mutant cells were grown in suspension at 37 °C in the same
medium with 10% fetal bovine serum. No clones had been
growing more than 2 months in continuous culture when pre-
pared for glycomic analyses.
Preparation of Cells for Glycomic Analyses—Cells growing in
monolayer culture were grown to confluency. Medium was
removed; 5 ml of phosphate-buffered saline containing 1 mM
CaCl2, 1mMMgCl2, and 1mMMnCl2 (PBS) was added; and the
cells were scraped into PBS, centrifuged, and washed three
times with PBS. An aliquot of the third resuspension was
counted to determine the total number of cells in the final pel-
let. The pellet was resuspended in 1 ml of PBS, transferred to a
Microfuge tube, and pelleted at 800  g. The supernatant was
aspirated, and the cell pellet was stored at80 °C and shipped
FIGURE 1. Altered N-glycans and O-GalNAc glycans in the CHO mutants
analyzed here. A loss or reduction of a sugar residue at a particular position
is indicated with a circled , and the gain of a sugar residue is shown by a
circled. Symbolic nomenclature is presentedasoutlinedby theConsortium
for Functional Glycomics Nomenclature Committee. Full details are available
on line.
TABLE 1
Biochemical changes in the CHO glycosylation mutants in this study
Glycomic Analyses of CHO Cell Mutants
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on dry ice. Suspension cultures were grown to 8–10  105
cells/ml, washed with PBS three times, and processed as for
monolayer cells.
Reduction and Carboxymethylation—Approximately 1.2 
108 cells from each CHO cell line (3  108 in the case of the
LEC12 mutant) were sonicated in extraction buffer (25 mM
Tris, 150 mM NaCl, 5 mM EDTA and 1% CHAPS, pH 7.4) and
then dialyzed against 4 4.5 liters of 50 mM ammonium bicar-
bonate, pH 8.5, at 4 °C for 48 h as described previously (8). After
dialysis, the sample was lyophilized and then reduced in 1ml of
50mMTris-HCl buffer, pH 8.5, containing 2mg/ml dithiothre-
itol. Reduction was performed under a nitrogen atmosphere at
37 °C for 1 h. Carboxymethylation was carried out by the addi-
tion of iodoacetic acid (5-foldmolar excess over dithiothreitol),
and the reactionwas allowed to proceed under a nitrogen atmo-
sphere at room temperature in the dark for 2 h. Carboxymeth-
ylationwas terminated by dialysis against 4 4.5 liters of 50mM
ammonium bicarbonate, pH 8.5, at 4 °C for 48 h. After dialysis,
the sample was lyophilized.
Tryptic Digest—The reduced carboxymethylated proteins
were digested with N-p-tosyl-L-phenylalanine chloromethyl
ketone-pretreated bovine pancreas trypsin (EC 3.4.21.4; Sigma)
for 16 h at 37 °C in 50 mM ammonium bicarbonate buffer, pH
8.4. The products were purified by C18 Sep-Pak (Waters) as
described previously (9).
Sep-Pak Separation of Released Glycans from Peptides—The
reverse-phase C18 Sep-Pak cartridge was primed sequentially
with 5 ml of methanol, 5 ml of 5% acetic acid (v/v), and 5 ml of
propan-1-ol before being re-equilibrated with 10 ml of 5% ace-
tic acid (v/v). The sample was then dissolved in a minimum
volume of 5% acetic acid (v/v) and loaded directly onto the
Sep-Pak. Elutionwas achieved using 3ml of 5% acetic acid (v/v),
followed by 2ml each of 20, 40, 60, and 100% propan-1-ol in 5%
acetic acid (v/v). Each elution step was collected, reduced in
volume on a SpeedVac, and lyophilized (9).
Peptide N-Glycosidase F Digestion of Glycopeptides—Peptide
N-glycosidase F (EC 3.5.1.52; Roche Applied Science) digestion
was carried out in 200l of ammoniumbicarbonate (50mM, pH
8.5) for 16 h at 37 °C using 3 units of enzyme. The reaction was
terminated by lyophilization, and the released N-glycans were
separated from peptides and O-glycopeptides by C18 Sep-Pak
(Waters) as described previously (9).
Sep-Pak Separation of Permethylated Glycans—The reverse-
phase C18 Sep-Pak cartridge was primed sequentially with 5
ml of methanol, 5 ml of water, and 5 ml of acetonitrile before
being re-equilibrated with 10 ml of water. The lyophilized per-
methylated oligosaccharide sample was then dissolved in a
minimum volume of methanol and loaded directly onto the
Sep-Pak. Elution was achieved using 3 ml of water followed
by 2 ml each of 15, 30, 50, 75, and 100% acetonitrile in water
(v/v). Each elution step was collected, reduced in volume on
a SpeedVac, and lyophilized (9).
Reductive Elimination—O-Glycans were released by reduc-
tive elimination in 400 l of 0.1 M potassium borohydride solu-
tion (54 mg/ml of potassium hydroxide in water) at 45 °C for
16 h. The reaction was terminated by dropwise addition of gla-
cial acetic acid, followed by Dowex 50W-X8 (H) 50–100 mesh
(Sigma) chromatography and borate removal.
Endo--galactosidase Treatment—A portion of the underi-
vatizedN-glycan pool was dissolved in 100 l of 50 mM ammo-
nium acetate buffer, pH 5.8, and incubated at 37 °C with 50
milliunits of Escherichia freundii endo--galactosidase (EC
3.2.1.103). After 48 h, the sample was lyophilized and then per-
methylated before MALDI-TOF analysis.
Derivatization for MALDI-TOF and Tandem Mass Spec-
trometry Analysis—Permethylation was performed using the
sodium hydroxide procedure, as described previously (9). 1 g of
sodium hydroxide pellets were crushed in a glass mortar with 3
ml of distilled anhydrous DMSO. From the resulting slurry, 1
ml and 200 l of methyl iodide were added to the lyophilized
sample. The mixture was then shaken for 10 min before the
reaction was quenched by dropwise addition of water. The per-
methylated sample was then extracted into 1 ml of chloroform
and washed four times with 1 ml of water. The chloroform was
then removed under a stream of nitrogen.
Partiallymethylated alditol acetates were prepared fromper-
methylated samples for GC-MS linkage analysis as described
previously (10). The permethylated glycans were hydrolyzed
with 2 M trifluoroacetic acid for 2 h at 121 °C, reduced with 10
mg/ml sodium borodeuteride in 2 M aqueous ammonium
hydroxide at room temperature for 2 h, and then acetylated
with acetic anhydride at 100 °C for 1 h.
Mass Spectrometric Analysis—MALDI-TOF data were
acquired on a Voyager-DE STR mass spectrometer (Applied
Biosystems, Foster City, CA) in the reflectron mode with
delayed extraction. Permethylated sampleswere dissolved in 10
l of 80% (v/v) aqueous methanol, and 1 l of dissolved sample
was premixedwith 1l of matrix (20mg/ml 2,5-dihydroxyben-
zoic acid in 80% (v/v) aqueous methanol), spotted onto a target
plate, and dried under vacuum.
FurtherMS/MS analyses of peaks observed in theMS spectra
were carried out using a 4800MALDI-TOF/TOF (Applied Bio-
systems) mass spectrometer. The potential difference between
the source acceleration voltage and the collision cell was set to
1 kV, and argon was used as collision gas. The 4700 calibration
standard kit, calmix (Applied Biosystems), was used as the
external calibrant for theMSmode, and [Glu1] fibrinopeptide B
human (Sigma) was used as an external calibrant for the
MS/MS mode.
The exceptionally high mass signals were observed during
additional MS experiments carried out on the 4800 MALDI-
TOF/TOF. The MALDI was tuned to specifically allow the
transmission of higher mass ions at the expense of those at
lower mass by manipulation of the lens voltages within
Source 1.
GasChromatography-MSLinkageAnalysis—GC-MS linkage
analysis of partially methylated alditol acetates was carried out
using a PerkinElmer Life Sciences Clarus 500 instrument fitted
with an RTX-5 fused silica capillary column (30 m 0.32 mm
internal diameter, Restek Corp.). The sample was dissolved in
hexane and injected onto the column at 60 °C. The columnwas
maintained at this temperature for 1 min and then heated to
300 °C at a rate of 8 °C/min.
AutomatedMSandMS/MSAnalysis—Annotation of theMS
and MS/MS data was achieved with assistance from the Car-
Glycomic Analyses of CHO Cell Mutants
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toonist algorithm (11) and the GlycoWorkbench software suite
(12).
RESULTS ANDDISCUSSION
To prepare samples for mass spectrometry, washed cell pel-
lets from wild type CHO cells grown in monolayer or suspen-
sion, as well as nine lectin-resistant mutants (Lec1, Lec2,
Lec3.2.8.1, Lec4, LEC10, LEC11, LEC12, Lec13, and LEC30)
grown in suspension, were sonicated, reduced and carboxym-
ethylated, and digested with trypsin. Preparation of tryptic gly-
copeptides facilitates the release ofN- andO-glycans by means
of peptideN-glycosidase F digestion and reductive elimination,
respectively. Permethylation of the purified glycan populations
was employed to enhance the sensitivity of the mass spectro-
metric analysis and to direct the fragmentation within tandem
MS analyses.
Matrix-assisted laser desorption ionization (MALDI)-MS
was employed to produce an initial profile of singly charged,
sodiatedmolecular ions ([MNa]), the results of which were
used to select target ions for further analysis by tandemMS/MS
techniques and supplementary experiments such as enzymatic
digestion and linkage analysis. Although not fully quantitative,
recent studies have succeeded in demonstrating that
MALDI-MS analyses of permethylated glycans provides reli-
able relative quantitation information based on signal intensi-
ties, particularly when comparisons aremade over a small mass
range of single ion peaks in the same spectrum (13).
Molecular ions observed in theMS analysis were subjected to
MS/MS analysis, affording sequence informative fragment
ions, providing information concerning structural features
such as antennal structures, branching patterns, and some link-
age positions. Linkage analysis by GC-MS, in concert with the
mass spectrometric profiling information, facilitates the assign-
ment of primary structural aspects, such as glycosidic bond
positions and monosaccharide constituents. Enzymatic digests
utilizing endo--galactosidase were also employed to confirm
the presence of poly-N-acetyllactosamine structures (Gal1–
4GlcNAc)n (14).
The assignments of N-glycan spectra were carried out with
the assistance of Cartoonist (11, 15), a bespoke algorithm
designed to mimic the human approach to the analysis and
assignment of N-glycan MALDI spectra. Cartoonist searches
the raw MS data for peak envelopes and uses knowledge of the
biosynthetic pathways to present the user with the most likely
permethylated carbohydrate structures for each signal.MS/MS
spectrawere assignedwith the support of theGlycoWorkbench
suite (12) of software tools, designed to assist the experts during
the annotation of glycan fragment spectra. The graphical inter-
face of GlycoWorkbench provides an environment in which
structure models can be rapidly assembled, automatically
matched with MSn data, and compared to assess the best
candidate.
Due to the finding that CHO cellsmake not onlymultianten-
nary structures but also highly extended LacNAc repeats, the
annotations are simplified throughout by using biantennary
structureswith the extensions listed in parentheses.Unless spe-
cifically noted, such structures are present as a mixture of bi-,
tri-, and tetra-antennary glycans with varying numbers of
LacNAc extensions and terminal NeuAc, NeuGc, or Fuc. Based
on GC-MS data, core Fuc and bisecting GlcNAc residues are
annotatedwithin the biantennary structure.When discussed in
the text, the total number of LacNAc units added to the pen-
tasaccharide chitobiose core is given.
Glycans ofWild Type CHOCells Grown inMonolayer Versus
Suspension Culture—CHO cells grown in monolayer (mCHO)
or in suspension (sCHO) were subjected to glycomic profiling
by MALDI-MS analysis. A mass spectrum obtained from the
peptide N-glycosidase F-released and -permethylated N-gly-
cans from a typical monolayer preparation of cells is shown in
Fig. 2, with the corresponding O-glycan spectrum in Fig. 3B. A
selected mass range comparison of the mCHO sample with the
sCHO sample is illustrated in Fig. 4. Complete compositional
assignments can be found in supplemental Tables S1 and S2.
TheN-glycan spectra for mCHO and sCHO exhibited a sim-
ilar range of structures. A full complement of high mannose
N-glycans was observed (m/z 1579.8, 1783.9, 1988.2, 2192.1,
and 2396.1), aswell as a series of complexN-glycans comprising
a mixture of bi-, tri-, and tetra-antennary structures, fucosy-
lated on the core and bearing multiple LacNAc extensions,
capped with sialic acid residues (n 1–3). Very little evidence
was observed for the presence of hybrid N-glycans in wild type
CHO samples. Although some monosaccharide compositions
could potentially be attributed to putative hybrid N-glycans,
MS/MS analysis of theseminor peaks yielded no definitive indi-
cation of hybrid structures, leading us to conclude that if they
are present it is at very low abundance. Sialic acid was predom-
inantly in the form of NeuAc, although NeuGc was present in a
small proportion of sialylatedN-glycans. Thismay be partly due
to fetal bovine serum glycoprotein contamination (16), but it is
known that CHO cells synthesize small amounts of CMP-
NeuGc (17). It is advantageous that most CHO sialic acid is
NeuAc because NeuGc is not desirable in recombinant thera-
peutic glycoproteins due to the high levels of circulating anti-
NeuGc antibodies in human serum (18).
Indirect evidence for trace amounts of N-glycans with an
unsubstitutedGlcNAcwas also obtained frombothmCHOand
sCHO spectra. Consistent with the presence of the bisecting
GlcNAc in complex N-glycans, GC-MS linkage data showed
very low relative abundance of 3,4,6-linked mannose (supple-
mental Table S3). This result was unexpected because no
Mgat3 gene transcripts (19) or GlcNAcT-III activity (19–21)
has been detected in wild type CHO cells. The GC-MS and
MALDI-TOF data, however, suggest that theMgat3 gene is not
completely silent in the Pro5 line of CHO cells. By contrast,
there was no evidence of N-glycans with more than one fucose
residue. This suggests that the Fut genes known to be encoded
in the CHO genome and activated in the LEC11, LEC12, and
LEC30 glycosylation mutants (1) are turned off in Pro5 CHO
cells. Although it is possible (although very unlikely, based upon
exhaustive MS/MS experiments) that in some fucosylated
N-glycans of CHO cells the single fucose is actually on an
antenna instead of in the core, the abundance would have to be
very low because CHO cells do not bind antibodies that recog-
nize fucose in the oncofetal antigens Lex, sLex, or VIM-2 (4, 22).
Overall, the most abundant structures in both the mCHO
and sCHO preparations were a series of core-fucosylated
Glycomic Analyses of CHO Cell Mutants
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FIGURE 2.MALDI-TOFMSprofiles of thepermethylatedN-linkedglycansderived fromwild typeCHOcells grown inmonolayer. For complete annotation of
the spectrum, see supplemental Table S1. Datawere obtained from the 50%MeCN fraction, and all molecular ions are present in sodiated form ([MNa]).
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asialoglycans bearing between 2 and 26 LacNAc units
(Fuc1Hex5–29HexNAc4–28). The main difference between the
monolayer and a suspension of CHO preparations was a varia-
tion in the level of sialylation,with the sCHOpreparation show-
ing a slight decrease in relative abundance of sialylated N-gly-
cans compared with the mCHO sample. Direct comparison of
two related species in each spectrum, a putative tri-antennary,
core-fucosylated N-glycan with a single NeuAc (m/z 3054.5)
and an asialo form of otherwise identical composition (m/z
2693.3), yielded a ratio of1:3 (sialylated:nonsialylated) in the
sCHO sample versus 1:1.5 in the mCHO sample. These peaks
are highlighted in green in Fig. 4.
TheO-glycan spectra fromwild type CHO show a simple set
of core 1 structures, mono- or di-sialylated by NeuAc (Fig. 3),
and the core 1 disaccharide (supplemental Table S2). Aswas the
case for the N-glycans, both the mCHO and sCHO O-glycan
spectra were very similar, although the cells grown in mono-
layer again have a slightly higher degree of relative sialylation.
An important consideration in interpreting the MS spectra
was the likelihood that N-glycans of the same m/z would
include different isobaric structures. This was examined by
multiple MS/MS fragmentation experiments of selected ions
within the spectra of each CHO glycosylation mutant, and
exemplar data are presented. Fig. 5 shows the species at m/z
4040.9 in the sCHO sample (Fig. 4A, FucHex9HexNAc8, high-
lighted in yellow) subjected toMS/MS analysis. The y ion atm/z
474.0 together with its complementary b ion atm/z 3591.0 con-
firm that the fucose is preferentially carried on the proximal
GlcNAc residue of the N-glycan core, as opposed to being on
either antenna. This was further supported by the presence of
4,6-linkedGlcNAcwithin theGC-MS linkage analysis (see sup-
plemental Table S3). The diagnostic b ions at m/z 935.1 and
1383.9 together with their corresponding y ions at m/z
3128.9 and 2680.6 are consistent with the glycosidic cleavage
of LacNAc repeats. Additional y ion fragments (m/z 1781.4
and 2230.5) serve to further confirm the presence of long
polyLacNAc extensions. These signals are also among the
most prominent within the spectrum, suggesting that the
most abundant isoform for the molecular ion at m/z 4040.9 is
an extended bi-antennary N-glycan with five LacNAc units on
one arm and one on the other. Overall, however, the mass at
4040.9 consists of a heterogeneous mixture of bi-, tri-, and tet-
FIGURE3.Comparisonbetween theMALDI-TOFMSprofiles of thepermethylatedO-glycansderived fromwild typeCHOcells grown in suspension (A)
and wild type CHO cells grown in monolayer (B). Data were obtained from the 35% MeCN fraction, and all molecular ions are present in sodiated form
([M Na]).
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ra-antennary glycans with varying lengths of polyLacNAc exten-
sion, as indicated by the presence of signals consistent with
multiple glycosidic cleavages that reveal the extent of the
branching on the core. Peaks at m/z 1767.3, 2217.3, 2665.7,
and 3114.3 establish that there are two branching points in
the molecule (thus a tri-antennary N-glycan), whereas a
minor signal at m/z 2203.5 ((OH)3Fuc1Hex5HexNAc4, three
branching points), implies the presence of a small amount of
tetra-antennary N-glycans.
These interpretations were further confirmed by endo--ga-
lactosidase digestion of wild type CHO samples prior to per-
methylation. This enzyme acts to preferentially cleave the1–4
linkage of unbranched, repeating polyLacNAc structures
(GlcNAc1–3Gal1–4)n (14). Endo--galactosidase treat-
ment gave rise to signals at m/z 518, 722, and 1083 (data not
shown), corresponding to the release of internal HexNAcHex
from polyLacNAc repeats, nonreducing HexHexNAcHex from
polyLacNAc antennae, and terminal NeuAcHexHexNAcHex.
The presence of these abundant signals, along with the lack of
any 3,6-linked galactose in linkage analysis data, confirms that
polyLacNAc chains were linear, rather than branched. Addi-
tionally, information regarding the number of antennae that are
extendedby polyLacNAc chains can be inferred by using signals
corresponding to the enzyme-trimmed core structures. For
example, a signal at m/z 1836.0 corresponds to a core-fucosy-
lated, bi-antennary N-glycan with both antennae trimmed by
the action of endo--galactosidase. Similarly, a signal at m/z
2081.1 demonstrates that each arm of a tri-antennary structure
can be extended, and m/z 2326.3 confirms that CHO cells can
extend all four of their antennae with LacNAc repeats.
In summary, the Pro5 strain of CHO cells synthesizes an
unexpectedly broad range of complexN-glycans, oligomannose
N-glycans, very few hybridN-glycans, and a simple set ofmucin
O-glycans. Other less abundant O-glycans, including O-man-
nose or O-fucose glycans, were not detected as obvious peaks
but could be detected by MS/MS analysis of species of the
expected mass (data not shown). Trace amounts of NeuGc are
present in CHO glycans, but the major sialic acid is NeuAc.
ManyN-glycans carry a core fucose, and none carry more than
one fucose.
FIGURE4.Comparisonbetween theMALDI-TOFMSprofiles of thepermethylatedN-glycansderived fromwild typeCHOcells grown in suspension (A)
andwild type CHO cells grown inmonolayer (B).Datawere obtained from the 50%MeCN fraction and allmolecular ions are present in sodiated form ([M
Na]). The peaks atm/z 2623 and 3054 are highlighted in green to better aidmeaningful comparison. The ion atm/z 4040.9 (highlighted yellow) corresponds to
the exemplar MS/MS shown in Fig. 5.
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CHO Glycans Lacking a Single Sugar, Lec2 (Sialic Acid) and
Lec13 (Fucose)—CHO cell mutants that belong to the Lec2
complementation group have a mutation in the Slc35a1 open
reading frame and are unable to translocate CMP-sialic acid
into the lumen of the Golgi apparatus, resulting in markedly
reduced levels of sialylation of glycoproteins and gangliosides
(23). A selected mass range comparison between a typical
MALDI-TOF MS profile of the permethylated N-glycans from
Lec2 CHO cells and those from wild type CHO cells grown in
suspension is shown in Fig. 6. The N-glycans from Lec2 cells
were consistent with the mutation, and no sialylated species
were observed (supplemental Table S1). This is interesting
because previous analyses have shown that glycoconjugates
made by Lec2 cells have a small amount of sialic acid (24, 25).
Themost abundant glycans produced by the Lec2CHOmutant
were a series of asialo, core-fucosylated N-glycans, possessing
between 2 and 7 LacNAc units (Fuc1Hex5–10HexNAc4–9). The
O-glycan profile of the Lec2 CHOmutant (data not shown) was
similarly affected by the alteration in sialylation of glycoconju-
gates. Only the unsubstituted core 1 structure was observed at
m/z 534.0 (supplemental Table S2).
Lec13 mutant CHO cells exhibit reduced expression of the
Gmd gene, resulting in a decrease in GDP-Man-4,6-dehy-
dratase activity and concomitant decreases in levels of GDP-
fucose and fucosylated glycans (26–28). Fig. 6 compares a
selected mass range between the MALDI-TOF MS profiles of
permethylated N-glycans derived from Lec13 mutant and wild
type CHO cells grown in suspension. There is a dramatic
decrease in the level of fucosylatedN-glycans in Lec13, with an
increase in the relative abundance of the related, nonfucosy-
lated N-glycans. This is exemplified by comparison of
the peaks at m/z 3417.8 (Hex8HexNAc7) and 3591.8
(Fuc1Hex8HexNAc7). The wild type sCHO sample shows an
approximate fucosylated-to-nonfucosylated ratio of 5.3:1,
whereas the Lec13 mutant exhibits the reverse with a fucosy-
lated-to-nonfucosylated ratio of 0.125:1. Nevertheless, fucose
was transferred to Lec13 N-glycans (Fig. 6 and supplemental
Table S1), an observation further confirmed by GC-MS linkage
analysis showing trace levels of terminal fucose and 4,6-linked
GlcNAc (see supplemental Table S3). Consistent with this,
Lec13 cells bound a small amount of the lectins Pisum sativum
agglutinin and Aleuria aurantica lectin, even when grown in
dialyzed serum (supplemental Fig. S1). However, Lec13 cells
did not bind antibodies that recognize fucose on N-glycan
antennae (supplemental Fig. S1). The transfer of a small
amount of fucose by Lec13 cells could be due to a number of
factors, including the Lec13 mutation being “leaky,” the pres-
ence of trace amounts of fucose from serum glycoproteins
being utilized by a scavenger pathway (29), or the presence of a
low frequency of revertants in the population (30). Other stud-
FIGURE 5.MALDI-TOF/TOFMS/MS spectrumof thepermethylatedN-glycanatm/z4040. 9, derived from theN-glycan spectrumofwild typeCHOcells
grown in suspension (Fig. 4, highlighted in yellow).Assignments of the fragment ionsgenerated andalternative antennal arrangements are shown. The ion
highlighted in red represents the cleavage of multiple antennae in a fashion that does not facilitate clear annotation.
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ies have reported small amounts of GDP-fucose in Lec13 cells
(31). Evidence for trace levels of N-glycans with a bisecting
GlcNAc was also obtained in the Lec13 MALDI-TOF profile,
with GC-MS linkage data showing very low relative abundance
of 3,4,6-linkedmannose. Themost abundantN-glycans produced
by the Lec13 CHO mutant were a series of asialo, mono-, or di-
sialylated core nonfucosylated glycans, possessing between 2 and
18 LacNAc units (NeuAc0–3Hex5–21HexNAc4–20).
The O-glycan profile of Lec13 (supplemental Table S2) was
unaffected by the fucosylation defect, although it should be
noted that O-fucose glycans synthesized by CHO cells (32) are
affected5 butwere of such low abundance as to only be observed
by MS/MS analysis in spectra of wild type CHO cells (data not
shown).
5 R. S. Haltiwanger, personal communication.
FIGURE 6. Selected mass range comparison between the MALDI-TOF MS profiles of the permethylated N-glycans derived fromwild type sCHO cells
(A), Lec2 sCHO (B), andLec13 sCHO (C). For complete annotationof the spectra, see supplemental Table S1. Datawere obtained from the50%MeCN fraction,
and all molecular ions are present in sodiated form ([M Na]).
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CHO N-Glycans with Altered Branching, Lec4 and LEC10—
Lec4 CHO mutants result from mutation of the Mgat5 gene
open reading frame leading to loss of the ability to make
GlcNAc(1,6)Man(1,6)-branched N-glycans catalyzed by
GlcNAcT-V (2, 33). MALDI-TOF MS profiling of permethyl-
ated N-glycans released from Lec4 CHO glycoproteins pro-
duced an altered fingerprint when compared with the wild type
(Fig. 7). The ratios of the abundance ofN-glycans carryingmul-
tiple LacNAc units and thus probable multiantennary N-gly-
canswere characteristically different, with a shift toward poten-
tial bi- and tri-antennary N-glycans rather than putative tetra-
antennary N-glycans. A good example of this characteristic
feature is the comparison between the relative abundances of a
potential tri-antennary glycan (m/z 2693, Fuc1Hex6HexNAc5)
and that of a related potential tetra-antennary structure (m/z
3143, Fuc1Hex7HexNAc6). These peaks are highlighted in green
FIGURE7.Selectedmass rangecomparisonbetween theMALDI-TOFMSprofilesof thepermethylatedN-linkedglycansderived fromCHOcells grown
in suspension (A), theLec4mutant cell line (B), and theLEC10mutant cell line (C).Peakshighlighted ingrayorgreen arepresentedas such for comparative
purposes (see text). For complete annotationof the spectra, see supplemental Table S1.Datawereobtained from the50%MeCN fraction andallmolecular ions
are present in sodiated form ([M Na]).
Glycomic Analyses of CHO Cell Mutants
5768 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 8•FEBRUARY 19, 2010
 at Im
perial College London on Septem
ber 18, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
to aid comparison in Fig. 7. The ratio has shifted from 3:5 in the
wild type in favor of the putative tetra-antennary N-glycan, to
3:1 in favor of the putative tri-antennary N-glycan in the Lec4
mutant. These data indicate that the Lec4mutant has a reduced
ability to create multiantennary structures, an observation fur-
ther borne out by GC-MS linkage analysis (see supplemental
Table S3), which showed that the cell line did not produce 2,6-
linked mannose, consistent with the absence of GlcNAcT-V.
For a summary of the N-glycans observed, see supplemental
Table S1. It can be seen that despite the lack of a 1,6-branch,
the mutant still produces large N-glycans bearing between 2
and 20 LacNAc units (Fuc1Hex5–23HexNAc4–22). This demon-
strates that the polyLacNAc extensions occur on other anten-
nae in the absence of the 1,6-GlcNAc branch. The O-glycan
profile of the Lec4 CHO mutant (supplemental Table S2) is
unaffected by the loss of GlcNAcT-V as expected, and it was
identical to that observed in the wild type sCHO sample
(Fig. 3A).
LEC10 CHO cell mutants have a gain-of-function mutation,
resulting from the activation of the Mgat3 gene (19, 20) that
FIGURE 8. Selectedmass range comparison between theMALDI-TOFMS profiles of the permethylatedN-linked glycans derived fromwild type CHO
cells grown in suspension (A), the Lec1 mutant cell line (B), and the Lec3. 2.8.1 mutant cell line (C). For complete annotation of the spectra, see
supplemental Table S1. Data were obtained from the 50%MeCN fraction, and all molecular ions are present in sodiated form ([M Na]).
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encodes GlcNAcT-III, the glycosyltransferase responsible for
the addition of the bisectingGlcNAc residue linked1–4 to the
core mannose residue of N-glycans. Fig. 7 shows a MALDI-
TOF MS selected mass range comparison between permethyl-
atedN-glycans derived from LEC10 mutant cells and wild type
sCHO. It is evident that the LEC10 mutant has a drastically
altered N-glycan profile, with each major constituent corre-
sponding to a putative bisected structure (the threemost abun-
dant peaks in the mass range have been highlighted in gray in
Fig. 7, along with their sCHO counterparts, to aid comparison).
These could of course reflect truncated antennae missing a Gal
residue, but not only were such species not observed in wild
type sCHO N-glycans, the abundance of 3,4,6-linked mannose
within the LEC10 GC-MS linkage data when compared with
the sCHO samples (see supplemental Table S3) verifies that
LEC10 N-glycans are predominantly modified with a bisect-
ing GlcNAc residue, consistent with the expression of
GlcNAcT-III in LEC10. The LEC10 mutant produces core-fu-
cosylated N-glycans with a large number of LacNAc units
(2–15, Fuc1Hex7–18HexNAc7–18), although significantly less
than in the wild type sCHO sample. This may suggest that the
addition of the bisecting GlcNAc inhibits polyLacNAc exten-
sion or 1,6-branching as has been proposed (34). However,
GC-MS analysis revealed a considerable proportion of 2,6-
linked Man consistent with 1,6-branching (supplemental
Table S3). In addition, glycoproteins from LEC10 CHO cells
bind L-PHA much better than CHO cells.6 For a summary of
the N-glycans observed in LEC10, see supplemental Table S1.
TheO-glycan profile of the LEC10CHOmutant (supplemental
Table S2) is unaffected by the genetic modification and was
identical to that observed in the wild type sCHO sample
(Fig. 3A).
CHO Mutants That Lack Complex and Hybrid N-Glycans,
Lec1 and Lec3.2.8.1—Lec1mutants originate from an insertion
or deletion within theMgat1 gene open reading frame, result-
ing in a loss of GlcNAcT-I activity (17) and a mutant CHO cell
incapable of synthesizing complex or hybrid N-glycans. A
selected mass comparison between typical MALDI-TOF MS
profiles of the permethylated N-glycans from Lec1 and wild
type CHO cells grown in suspension is displayed in Fig. 8. The
most prominent feature of the spectrum is the abundant
Man5GlcNAc2 N-glycan at m/z 1579.9, which represents the
accumulated substrate of GlcNAcT-1. In addition small
amounts of Man5GlcNAc2Fuc1 were observed. By contrast, in
wild type CHO cells Man8GlcNAc2 and Man9GlcNAc2 were
the predominant high mannose N-glycans. Surprisingly,
extremely small signals typical of complex N-glycans were
observed. MS/MS analyses on these signals, together with
GC-MS linkage data indicating trace levels of terminal galac-
tose (see supplemental Table S3), confirmed a trace presence of
N-glycans bearing limited LacNAc extensions with some sialy-
lation. This is probably due to a very small degree of contami-
nation of serum glycoproteins that carry complex N-glycans,
because the Mgat1 mutation in the Lec1 mutant analyzed
caused a loss of 203 C-terminal amino acids and generates an
inactive enzyme (17). Alternatively, and although unlikely it
cannot be ruled out, another glycosyltransferase may substi-
tute for GlcNAcT-1 in its absence. For a summary of the
N-glycans observed in Lec1, see supplemental Table S1. The
O-glycan profile of the Lec1 CHO mutant (supplemental
Table S2) is unaffected by the genetic modification and was
identical to that observed in the wild type sCHO sample
(Fig. 3A).
Lec3.2.8.1 is a CHO mutant carrying four glycosylation
mutations corresponding to insertions/deletions in the Gne
(Lec3), Slc35a1 (Lec2), Slc35a2 (Lec8), andMgat1 (Lec1) open
reading frames, respectively. This multiple glycosylation
mutant gives rise to severely truncated N- and O-glycans (35,
36), and due to decreased activity of UDP-GlcNAc-2-
epimerase, the CMP-sialic acid Golgi transporter, the UDP-Gal
Golgi transporter, and GlcNAcT-I. MALDI-TOF MS profiles
obtained from samples of this CHO mutant (Fig. 8C) are con-
sistent with these mutations, with complex N-glycans being
almost completely absent. However, as with the Lec1 mutant
described above, small traces of signals consistent with the
presence of complex N-glycans were observed. The Mgat1
mutation in this mutant removes 56 amino acids from the C
terminus of GlcNAcT-1 (17). Therefore, Lec3.2.8.1 cells should
have, if anything, more GlcNAcT-1 activity than the Lec1
mutant discussed above. The fact that the small traces of com-
plex N-glycans are similar in Lec1 and Lec3.2.8.1 argues
strongly that they arose from serum glycoprotein contamina-
tion. For a summary of theN-glycans observed, see supplemen-
tal Table S1.
TheO-glycan profile of the Lec3.2.8.1 multiple glycosylation
mutant CHO cells (supplemental Table S2) is bereft of signals,
which is as predicted. The O-linked glycans should be trun-
cated to a singleGalNAc,which if unsubstituted proves difficult
to detect using the methods utilized here. The absence of any
larger O-glycans is a good indication that the mutations do
indeed restrict theO-glycosylation to at most a single GalNAc.
Therefore, recombinant glycoproteins made in Lec3.2.8.1 will
have no complex or hybrid N-glycans and only O-GalNAc at
O-glycan sites. The oligomannosyl N-glycans can be removed
by endoglycosidase H thereby generating a glycoprotein with
only GlcNAc at N-glycan sites and GalNAc at O-glycan sites.
This has been used to advantage for the crystallization of highly
glycosylated recombinant glycoproteins (37, 38).
CHOCells with -1,3-Fucose on Complex N-Glycans, LEC11,
LEC12, and LEC30—LEC11 gain-of-function CHO cell
mutants express an -1,3-fucosyltransferase (FucT-VIa or
FucT-VIb) due to the activation of the Fut6 gene, thereby gen-6 R. Bhattacharrya and P. Stanley, unpublished observations.
FIGURE 9. Selected mass range comparison between the MALDI-TOF MS profiles of the permethylated N-glycans derived from CHO cells grown in
suspension (A), theLEC11mutant cell line (B), theLEC12mutant cell line (C), and theLEC30mutant cell line (D).Only structures bearingmultiple fucoses
in themutant samples are annotated with structures to simplify the presentation, although all other glycan peaks are labeled with theirm/z values alone. For
complete annotationof the spectra, see supplemental Table S1.Datawereobtained fromthe50%MeCN fraction, andallmolecular ions arepresent in sodiated
form ([M Na]).
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erating Lex, sLex, and VIM-2 antennal structures (4, 39). Com-
parison of theN-glycan profile exhibited by the LEC11 andwild
type CHO cell lines (Fig. 9) demonstrates a substantial increase
in fucosylation among the N-glycans of the gain-of-function
mutant. The N-glycans observed in the sCHO sample carry no
more than one fucose residue, which is preferentially added to
the core rather than the antennae (Fig. 4 and Fig. 9A). By con-
trast, up to four fucose residues are present perN-glycan in the
FIGURE 10. Exemplar MALDI-TOF/TOF data of fucosylated N-glycans. A, MS/MS spectra of the permethylated N-glycan at m/z 2779.2, derived from the
N-linked spectrum of the LEC11 mutant cell line (Fig. 9B, highlighted), with the two main components of the peak indicated, a biantennary sialyl Lewisx
containing structure 1) and a biantennary Lewisx glycan 2). B, MS/MS spectrum of the permethylated N-glycan at m/z 2779.2, derived from the N-linked
spectrum of the LEC12 mutant cell line (Fig. 9C, highlighted). C, MS/MS spectrum of the permethylated N-glycan at m/z 3838.9, derived from the N-linked
spectrum of the LEC30mutant cell line (Fig. 9D, highlighted). Assignments of the fragment ions are shown. The ions highlighted in red represent the cleavage
of multiple antennae in a fashion that does not facilitate clear annotation.
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LEC11 complex N-glycan complement. GC-MS linkage analy-
sis (see supplemental Table S3) also demonstrates an increase
in both terminal fucose and 3,4-linkedGlcNAcwhen compared
with the sCHO wild type data, further corroborating the FucT
gain-of-function. Overall, the most abundant complex struc-
tures in the N-glycan profile of the LEC11 cells were fucosy-
lated, mono- or di-sialylated glycans, bearing between 2 and 16
LacNAc units (NeuAc0–2Fuc1–4Hex5–19HexNAc4–18). For a
summary of the N-glycans observed, see supplemental Table
S1. The O-glycan profile of the LEC11 CHO mutant (supple-
mental Table S2) was identical to that observed in the wild type
sCHO sample (Fig. 3A).
To define the position of the fucose in theN-linked profile of
the LEC11 mutant cell line, MS/MS experiments were carried
out. As exemplified in Fig. 10A (MS/MSprofile of themolecular
ion atm/z 2779.2,NeuAc1Fuc2Hex5HexNAc4), the diagnostic b
ions at m/z 486.3, 660.1, 847.2, and 1021.5 together with the
complementary y ions atm/z 2317.1, 2142.1, 1954.9, and 1780.8
implicate the presence of LacNAc, Lex, sialylated LacNAc, and
sLex terminal structures, respectively. Careful analysis of the
data provides evidence that the molecular ion at m/z 2779.2
consists of two main isomers, labeled 1) and 2) in Fig. 10A. The
relative abundances of the most prevalent fragment ions (m/z
1780.8 and 1021.5, for example) suggests that isomer 1) in Fig.
10A is present in the greatest quantity. This structure is a core-
fucosylated, bi-antennary N-glycan, with a simple LacNAc
antenna on one arm and an sLexmotif on the other. From these
data, it is therefore possible to deduce that LEC11mutants pref-
erentially fucosylate in the context of sLex terminal epitopes
once the core is fucosylated.
LEC12 CHO cells are gain-of-function mutants arising from
the activation of the Fut9 gene, and they express FucT-IX activ-
ity (40). The LEC12 N-glycan profile (Fig. 9B) demonstrates
both an increase in the relative abundance of fucosylation
events, and an increase in the number of fucose residues
attached to a single N-glycan, with up to seven such residues
observed on a single structure. This is consistent with GC-MS
linkage analysis (see supplemental Table S3), where the relative
abundance of terminal fucose in the LEC12 sample is far greater
than that of wild type sCHO cells. Evidence for trace levels of
TABLE 2
Summary table of the structural changes observed in the analysis of CHOmutants
The structural alterations shown here are based uponMALDI-TOF/TOFMS andMS/MS data.X, not detected; Ng, negligible amounts;, no significant changes; upward
arrows indicate an increase; downward arrows indicate a decrease; the number of arrows is indicative of the magnitude of change with three arrows being the greatest
(75%) and one arrow being the smallest (25%) percentage change from wild type CHO grown in suspension. Linkages are assigned according to known biosynthetic
pathways.
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bisecting GlcNAc was also observed by GC-MS linkage analy-
sis. Interestingly, sialylation was a relatively rare event, with
only structures bearing a single NeuAc residue being observed.
This is consistent with the addition of fucose precluding the
addition of sialic acid and previous work showing that LEC12
cells express Lex and VIM-2 but not sLex epitopes (22). For a
summary of the N-glycans observed in LEC12, see supplemen-
tal Table S1. The O-glycan profile of the LEC12 CHO mutant
(supplemental Table S2) was identical to that observed in the
wild type sCHO sample (Fig. 3A).
In similar fashion to the LEC11 analysis, MS/MS was once
again employed to determine the location of the fucose res-
idues in the LEC12 N-glycans. Fig. 10B shows the result of
such an analysis upon the molecular ion at m/z 2779.2
(NeuAc1Fuc1Hex5HexNAc4). The data reveal a series of diag-
nostic b ions atm/z 660.1 and 846.9 and concomitant y ions at
m/z 2142.5 and 1954.4. The presence of these signals, together
with the absence of fragment ions at m/z 486 (Hex1HexNAc1)
and 1021 (NeuAc1Fuc1Hex1HexNAc1), confirms the prefer-
ence of LEC12 to fucosylate in the context of Lex structures
rather than sLex once the core position is occupied, which is
consistent with the specificity of FucT-IX (41). There is evi-
dence for trace levels of sLex antennae, with very small y ion
peaks observed atm/z 2316.3 and 1781.4, corresponding to the
potential loss of an sLex antenna.
Activation of the Fut4 and Fut9 genes produces the gain-of-
function mutant LEC30, which exhibits FucT-IV and FucT-IX
-1,3-fucosyltransferase activities (40). Fig. 9C displays a typi-
cal permethylatedN-linked glycanmass spectrumderived from
LEC30 cells, compared with the corresponding mass range
from sCHO, LEC11, and LEC12 preparations. A significant
increase in the level of fucosylation is evident, with single struc-
tures bearing up to 14 fucose residues in LEC30 N-glycans.
Fucosylation of the polyLacNAc extensions was confirmed by
GC-MS linkage analysis that demonstrated a significant
increase in the levels of terminal fucose 3,4-linked GlcNAc
when compared with the wild type (supplemental Table S3).
This extremely high level of fucosylation sets the LEC30-
fucosylated N-glycans apart from those in LEC11 or LEC12
cells and is presumably caused by the expression of both the
Fut4 and Fut9 genes in LEC30 cells. Evidence for trace levels
of bisecting GlcNAc was observed in the MALDI profile,
with GC-MS linkage data showing very low relative abun-
dance of 3,4,6-linked mannose. Overall, the LEC30 cells pro-
duced mono- or di-sialylated complex N-glycans, with
between 2 and 13 LacNAc units bearing up to 14 fucose
residues (NeuAc0–2Fuc1–14Hex5–16HexNAc4–15). For a
summary of the LEC30 N-glycans observed, see supplemen-
tal Table S1. TheO-glycan profile of the LEC30 CHOmutant
(supplemental Table S2) was identical to that observed in the
wild type sCHO sample (Fig. 3A).
An exemplar MS/MS analysis of a highly fucosylated N-gly-
can from LEC30 (m/z 3838.9, Fuc5Hex7HexNAc6) is shown in
Fig. 10C. The fragment ions demonstrate that the glycan is
present in multiple isoforms (bi-, tri-, and tetra-antennary),
with fucose residues attached to every LacNAc unit giving ter-
minal Lex and a high probability of extended VIM-2 epitopes.
Clearly, LEC30 is the cell of choice for generating recombinant
glycoproteins with a large proportion of nonsialylated, 1,3-
fucosylated N-glycans.
Summary—The general conclusions of these analyses are
summarized in Table 2. All the data presented here have been
deposited in the Core C data base of the Consortium for Func-
tional Glycomics (42, 43) and are available on line. It is apparent
that CHO cells can make very large N-glycans with up to 26
LacNAc units. As mass spectrometers increase in sensitivity,
even larger masses may be detected. The number of LacNAc
units was reduced in Lec2, and more markedly reduced in
LEC12 and LEC30N-glycans, suggesting that terminal addition
of sialic acid facilitates polylactosamine extension on antennae
that themselves do not receive sialic acid, although fucose on a
LacNAc unit reduces polyLacNAc extension. It is of interest
that N-glycans from most lines derived from Pro5 CHO cells
exhibited trace amounts of N-glycans with the bisecting
GlcNAc as confirmed byGC-MS analysis. These did not appear
to be due to contamination of serum glycoproteins because the
contaminating N-glycans in Lec1 and Lec3.2.8.1 N-glycans did
not contain the bisecting GlcNAc. Because reverse transcrip-
tion-PCR did not detect Mgat3 transcripts in Pro5 RNA and
Pro5 cells have no GlcNAcT-III activity (19), this reflects the
superior sensitivity of mass spectrometry to detect very low
levels of GlcNAcT-III activity.
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